Ji Liu
Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, People�s Republic of China
Maopeng Yang
Department of Medical Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, People�s Republic of China
Rui Kong
Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, People�s Republic of China
Hua Chen
Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, People�s Republic of China
Yongwei Wang
Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, People�s Republic of China
Shangha Pan
Key Laboratory of Hepatosplenic Surgery, Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, People�s Republic of China
Hongchi Jiang
Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, People�s Republic of China
Bei Sun
Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, People�s Republic of China
PDF Fulltext XML References Citation
How to cite this article
Ji Liu, Maopeng Yang, Rui Kong, Hua Chen, Yongwei Wang, Shangha Pan, Hongchi Jiang and Bei Sun, 2015. Icotinib Enhances Bufalin-Induced Apoptosis via the Suppression of PI3K/Akt Signaling Pathway in Human Colon Cancer Cells. International Journal of Pharmacology, 11: 910-919.
DOI: 10.3923/ijp.2015.910.919
URL: https://scialert.net/abstract/?doi=ijp.2015.910.919
DOI: 10.3923/ijp.2015.910.919
URL: https://scialert.net/abstract/?doi=ijp.2015.910.919